Use of l-butylphthalide in the manufacture of medicaments for prevention and treatment of cerebral infarct

Details for Australian Patent Application No. 2004279655 (hide)

Owner Shijiazhuang Pharma. Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. Institute of Materia Medica, Chinese Academy of Medical Sciences

Inventors Peng, Ying; Wang, Xiaoliang; Yang, Jinghua; Feng, Yipu

Agent Griffith Hack

Pub. Number AU-B-2004279655

PCT Pub. Number WO2005/034936

Priority 200310100222.2 10.10.03 CN

Filing date 29 September 2004

Wipo publication date 21 April 2005

Acceptance publication date 25 September 2008

International Classifications

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07D 307/88 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/034936 Priority application(s): WO2005/034936

25 September 2008 Application Accepted

  Published as AU-B-2004279655

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004279661-A solid dosage form comprising a fibrate and a statin

2004279653-A confectionery product